147 related articles for article (PubMed ID: 2465995)
1. Control mechanisms of mediator release in human basophils and mast cells.
Marone G
Immunol Invest; 1988; 17(8-9):707-45. PubMed ID: 2465995
[No Abstract] [Full Text] [Related]
2. The pharmacologic control of mediator release from human basophils and mast cells.
Peters SP; Naclerio RM; Schleimer RP; MacGlashan DW; Pipkorn U; Lichtenstein LM
Respiration; 1986; 50 Suppl 2():116-22. PubMed ID: 3494282
[TBL] [Abstract][Full Text] [Related]
3. Membrane receptors for the IgG4 subclass on human basophils and mast cells.
Nakagawa T; de Weck AL
Clin Rev Allergy; 1983 Jun; 1(2):197-206. PubMed ID: 6201249
[No Abstract] [Full Text] [Related]
4. Histamine and sulfidoleukotriene release from human basophils: different effects of antigen, anti-IgE, C5a, f-Met-Leu-Phe and the novel neutrophil-activating peptide NAF.
Dahinden CA; Kurimoto J; Baggiolini M; Dewald B; Walz A
Int Arch Allergy Appl Immunol; 1989; 90(2):113-8. PubMed ID: 2479603
[TBL] [Abstract][Full Text] [Related]
5. Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
Eggleston PA; Kagey-Sobotka A; Proud D; Adkinson NF; Lichtenstein LM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):960-4. PubMed ID: 1691604
[TBL] [Abstract][Full Text] [Related]
6. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
Hofman J; Siergiejko Z; Kuczewska B; Chyrek-Borowska S
Arch Immunol Ther Exp (Warsz); 1984; 32(5):599-604. PubMed ID: 6085468
[TBL] [Abstract][Full Text] [Related]
7. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
8. Effect of lysophosphatidylserine on immunological histamine release.
Kolster L; Jensen C; Bruni A; Mietto L; Toffano G; Norn S
Biochim Biophys Acta; 1987 Feb; 927(2):196-202. PubMed ID: 2434138
[TBL] [Abstract][Full Text] [Related]
9. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion.
Marone G; Cirillo R; Genovese A; Marino O; Quattrin S
Life Sci; 1989; 45(19):1745-54. PubMed ID: 2480501
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.
Triggiani M; Cirillo R; Lichtenstein LM; Marone G
Int Arch Allergy Appl Immunol; 1989; 88(1-2):253-5. PubMed ID: 2468619
[TBL] [Abstract][Full Text] [Related]
11. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells.
Marone G; Casolaro V; Paganelli R; Quinti I
J Invest Dermatol; 1989 Aug; 93(2):246-52. PubMed ID: 2787823
[TBL] [Abstract][Full Text] [Related]
12. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid.
Fox CC; Moore WC; Lichtenstein LM
Dig Dis Sci; 1991 Feb; 36(2):179-84. PubMed ID: 1703070
[TBL] [Abstract][Full Text] [Related]
13. Forskolin inhibits the release of histamine from human basophils and mast cells.
Marone G; Columbo M; Triggiani M; Vigorita S; Formisano S
Agents Actions; 1986 Apr; 18(1-2):96-9. PubMed ID: 2425602
[TBL] [Abstract][Full Text] [Related]
14. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
Marone G; Columbo M; de Paulis A; Cirillo R; Giugliano R; Condorelli M
Agents Actions; 1986 Apr; 18(1-2):103-6. PubMed ID: 2425567
[TBL] [Abstract][Full Text] [Related]
15. Mediator release from human basophils and mast cells from lung and intestinal mucosa.
Fox CC; Kagey-Sobotka A; Schleimer RP; Peters SP; MacGlashan DW; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):130-6. PubMed ID: 2409011
[No Abstract] [Full Text] [Related]
16. Heterogeneous effects of protamine on human mast cells and basophils.
Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
[TBL] [Abstract][Full Text] [Related]
18. Human mast cells and basophils--structure, function, pharmacology, and biochemistry.
Schleimer RP; MacGlashan DW; Schulman ES; Peters SP; Adams GK; Adkinson NF; Lichtenstein LM
Clin Rev Allergy; 1983 Sep; 1(3):327-41. PubMed ID: 6201252
[No Abstract] [Full Text] [Related]
19. Role of human basophils and mast cells in the pathogenesis of allergic diseases.
Schleimer RP; Fox CC; Naclerio RM; Plaut M; Creticos PS; Togias AG; Warner JA; Kagey-Sobotka A; Lichtenstein LM
J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):369-74. PubMed ID: 2410478
[TBL] [Abstract][Full Text] [Related]
20. Histamine release from gut mast cells from patients with inflammatory bowel diseases.
Nolte H; Spjeldnaes N; Kruse A; Windelborg B
Gut; 1990 Jul; 31(7):791-4. PubMed ID: 1695160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
